Four-factor prothrombin complex concentrate plus andexanet alfa for reversal of factor Xa inhibitor–associated bleeding: Case series

JT Liu, P Elsamadisi, E Philips… - American Journal of …, 2022 - academic.oup.com
Abstract Purpose To manage factor Xa (FXa) inhibitor–associated bleeding, andexanet alfa
or 4-factor prothrombin concentrate (4F-PCC) has been used to restore hemostasis …
被引用次数：10 相关文章

Four-factor prothrombin complex concentrate plus andexanet alfa for reversal of factor Xa inhibitor–associated bleeding: Case series.

JT Liu, P Elsamadisi, E Philips… - American Journal of …, 2022 - search.ebscohost.com
Abstract Purpose To manage factor Xa (FXa) inhibitor–associated bleeding, andexanet alfa
or 4-factor prothrombin concentrate (4F-PCC) has been used to restore hemostasis …

Four-factor prothrombin complex concentrate plus andexanet alfa for reversal of factor Xa inhibitor-associated bleeding: Case series.

J Liu, P Elsamadisi, E Philips, KA Bauer… - American Journal of …, 2022 - europepmc.org
Purpose To manage factor Xa (FXa) inhibitor-associated bleeding, andexanet alfa or 4-
factor prothrombin concentrate (4F-PCC) has been used to restore hemostasis. However …

Four-factor prothrombin complex concentrate plus andexanet alfa for reversal of factor Xa inhibitor-associated bleeding: Case series

JT Liu, P Elsamadisi, E Philips… - American journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Purpose To manage factor Xa (FXa) inhibitor-associated bleeding, andexanet alfa or 4-
factor prothrombin concentrate (4F-PCC) has been used to restore hemostasis. However …

Four-factor prothrombin complex concentrate plus andexanet alfa for reversal of factor Xa inhibitor–associated bleeding: Case series

JT Liu, P Elsamadisi, E Philips… - American Journal of …, 2022 - academic.oup.com
Abstract Purpose To manage factor Xa (FXa) inhibitor–associated bleeding, andexanet alfa
or 4-factor prothrombin concentrate (4F-PCC) has been used to restore hemostasis …